| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Departments of Medicine (V.M.-A., L.F., R.G.) and Cardiovascular Genetics (S.E.H.), University College London Medical School, Whittington Hospital, London N19 3UA, United Kingdom; Harvard School of Public Health (V.M.-A., J.S., G.H.), Boston, Massachusetts 02115; Pennington Biomedical Research Center (D.A.Y., J.P.), Louisiana State University, Baton Rouge, Louisiana 70808-4124; and Department of Medicine, Diabetes, and Endocrinology Research Group (J.P.), University of Liverpool, University Hospital Aintree, Liverpool L9 7AL, United Kingdom
Address all correspondence and requests for reprints to: Jonathan Pinkney, M.D., University of Liverpool, Department of Medicine, Clinical Sciences Centre, Longmoor Lane, Liverpool L9 7AL, United Kingdom. E-mail: jpinkney{at}liverpool.ac.uk
Abstract
Circulating IL-6 levels are elevated in obesity. Although IL-6 is expressed in adipose tissue, neither its regulation nor cell of origin is well characterized. Here we investigated the ß-adrenergic regulation of IL-6 release in a combination of studies on humans and animals in vivo and cultured adipocytes in vitro. Human in vivo study: Human volunteers were infused with isoproterenol, norepinephrine, or saline {4 M:4F; mean (SD) age 35.5 (5.8) yr; body mass index 24.6 (4.2) kg/m-2}. Plasma IL-6 levels increased during a 3-h infusion of isoproterenol (P = 0.01) and fell 2 h post infusion (P = 0.05). IL-6 levels did not change significantly with either norepinephrine or saline. Murine in vivo study: C57BL6/J male mice were injected ip with dobutamine (ß1 agonist), clenbuterol (ß2), CL316243 (ß3), or saline placebo. Plasma IL-6 levels at 3 h were increased by clenbuterol (P = 0.02) and CL316243 (P = 0.02) but not dobutamine (P = 0.51), compared with placebo. In vitro studies: In human peripheral blood cells, lipopolysaccharide treatment enhanced secretion of IL-6 (vs. controls; P < 0.001), whereas isoproterenol inhibited IL-6 secretion (P = 0.012) and norepinephrine had no significant effect. In contrast, isolated human adipocytes and differentiated 3T3F442A adipocytes all rapidly secreted IL-6 in response to adrenergic agonists (P < 0.01, compared with untreated cells). We conclude that ß2/ß3 adrenoceptor stimulation on adipocytes, rather than macrophages, may be responsible for the increases in plasma IL-6 concentrations observed during sympathetic activation and in obesity.
This article has been cited by other articles:
![]() |
E. A. Kirk, Z. K. Sagawa, T. O. McDonald, K. D. O'Brien, and J. W. Heinecke Monocyte Chemoattractant Protein-1 Deficiency Fails to Restrain Macrophage Infiltration Into Adipose Tissue Diabetes, May 1, 2008; 57(5): 1254 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J-M Gonzalez-Clemente, C Vilardell, M Broch, A Megia, A Caixas, O Gimenez-Palop, C Richart, I Simon, A Martinez-Riquelme, J Arroyo, et al. Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes Eur. J. Endocrinol., July 1, 2007; 157(1): 31 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Wernstedt, A. Edgley, A. Berndtsson, J. Faldt, G. Bergstrom, V. Wallenius, and J.-O. Jansson Reduced stress- and cold-induced increase in energy expenditure in interleukin-6-deficient mice Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R551 - R557. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Lee, L. C. Sturgis, H. Labazi, J. B. Osborne Jr., C. Fleming, J. S. Pollock, M. Manhiani, J. D. Imig, and M. W. Brands Angiotensin II hypertension is attenuated in interleukin-6 knockout mice Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H935 - H940. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chen, S. Tsui, and T. J. Smith IL-1{beta} Induces IL-6 Expression in Human Orbital Fibroblasts: Identification of an Anatomic-Site Specific Phenotypic Attribute Relevant to Thyroid-Associated Ophthalmopathy J. Immunol., July 15, 2005; 175(2): 1310 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hakonarson, S. Thorvaldsson, A. Helgadottir, D. Gudbjartsson, F. Zink, M. Andresdottir, A. Manolescu, D. O. Arnar, K. Andersen, A. Sigurdsson, et al. Effects of a 5-Lipoxygenase-Activating Protein Inhibitor on Biomarkers Associated With Risk of Myocardial Infarction: A Randomized Trial JAMA, May 11, 2005; 293(18): 2245 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Hamid, S. A. Urhammer, D. P. Jensen, C. Glumer, K. Borch-Johnsen, T. Jorgensen, T. Hansen, and O. Pedersen Variation in the Interleukin-6 Receptor Gene Associates With Type 2 Diabetes in Danish Whites Diabetes, December 1, 2004; 53(12): 3342 - 3345. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. CLEMENT, N. VIGUERIE, C. POITOU, C. CARETTE, V. PELLOUX, C. A. CURAT, A. SICARD, S. ROME, A. BENIS, J.-D. ZUCKER, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects FASEB J, November 1, 2004; 18(14): 1657 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Lee, R. Leite, C. Fleming, J. S. Pollock, R. C. Webb, and M. W. Brands Hypertensive Response to Acute Stress Is Attenuated in Interleukin-6 Knockout Mice Hypertension, September 1, 2004; 44(3): 259 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Novakofski Adipogenesis: Usefulness of in vitro and in vivo experimental models J Anim Sci, March 1, 2004; 82(3): 905 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wolf, J. Sauk, A. Shah, K. Vossen Smirnakis, R. Jimenez-Kimble, J. L. Ecker, and R. Thadhani Inflammation and Glucose Intolerance: A prospective study of gestational diabetes mellitus Diabetes Care, January 1, 2004; 27(1): 21 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bell, A. Gagnon, and A. Sorisky TSH Stimulates IL-6 Secretion from Adipocytes in Culture Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): e65 - e65. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |